Skip to content

13F-HR filed by Foresite Capital Management IV, LLC

Foresite Capital Management IV, LLC filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-13, with 12 holding rows worth $205,283,000.

Accession
0001104659-20-094444
Filed
2020-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 12 entries on the cover page, a total value of $205,283,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $205,283,000 with VALUE read as thousands by filing date, 13F file number 028-18415. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KEROS THERAPEUTICS INC COM492327101Stock1,428,071$53,567,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW1,607,292$37,884,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock1,307,982$21,320,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK1,133,948$20,740,000thousands by filing date
VAXCYTE INC COM92243G108Stock620,821$19,624,000thousands by filing date
GENERATION BIO CO37148K100COM857,942$18,017,000thousands by filing date
MYOKARDIA INC62857M105COM126,492$12,222,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM2,843,893$9,925,000thousands by filing date
VOYAGER THERAPEUTICS INC92915B106COMMON STOCK516,751$6,521,000thousands by filing date
ORIC PHARMACEUTICALS INC68622P109COM125,000$4,216,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM25,000$635,000thousands by filing date
RETROPHIN INC761299106COM30,000$612,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-20-094444this filing2020-08-13acceptance time not in the bulk data set